Abstract:The endothelium represents an important source of, and a target for, inflammation in sepsis. Angiogenic factors and their receptors, including vascular endothelial growth factor (VEGF)/VEGF receptor and the angiopoietin/Tie2 signaling pathways, have recently received great attention in critically ill patients, including those with sepsis [1-3], because of their pivotal roles in both angiogenesis and microvascular permeability. VEGF, as the most potent proangiogenic factor, has already been identified as an important target for cancer therapy. Disassembly of an intact endothelial cell junction is necessary for the angiogenesis process. The endothelial barrier-breaking properties are indeed an important part of the VEGF role in the regulation of angiogenesis. However, a high dose or prolonged duration of VEGF may lead to excessive barrier-breaking effects. The favorable results observed with the only US Food and Drug Administration-approved anti-VEGF agent, bevacizumab, by Jeong and colleagues [4] are likely to provide potential advances for future therapeutic opportunities in sepsis. On the contrary, VEGF shows endothelial survival signals, and suppression of VEGF signaling inhibits endothelial survival and increases apoptosis, which in turn may contribute to the development of sepsis-induced organ dysfunction [5]. Furthermore, other than an independent function on endothelial cells, VEGF plays an important role in mobilizing endothelial progenitor cells under pathologic conditions such as cancer and sepsis. While the decrease of circulating endothelial progenitor cells (cEPCs) after anti-VEGF treatment is beneficial in cancer, this may not be so in sepsis. The endothelium is a chief target of sepsis-induced events, and clinical outcome in septic patients is largely dependent on the ability to reconstitute damaged endothelium. Indeed, several studies have observed an increase in cEPC numbers in septic patients and a correlation between cEPC concentration and survival. The increased number of cEPCs in sepsis might therefore be a consequence of the body’s attempt to limit vascular damage by inducing endogenous endothelial repair mechanisms. The dramatic decrease of cEPCs accompanied by anti-VEGF treatment may impair endothelial repair capacity and bring unfavorable effects in sepsis. The angiogenic factors and their soluble receptors therefore do have a complex role and seemingly play both good and bad roles during sepsis development and therapy. A certain level of VEGF is necessary for normalizing endothelial function, and abnormally high or low levels of VEGF might shift its role from endothelial protective to endothelial barrier disruptive. This view can also provide additional possible explanations for why Jeong and colleagues’ study suggests that a high dose of bevacizumab may have deleterious effects in an experimental sepsis model. Future studies on the dynamic change of the angiogenic factors, their soluble receptors and cEPC counts during and after each therapy, as well as the context-dependent role of them, may provide background data for using these angiogenic factors and their soluble receptors as therapeutic targets for sepsis treatment in clinical practice.

Endothelin-converting Enzyme-1-mediated Signaling in Adult Rat Ventricular Myocyte Contractility and Apoptosis During Sepsis.

Bigendothelin-1 via p38-MAPK-dependent mechanism regulates adult rat ventricular myocyte contractility in sepsis.

Advanced Glycation End Products Facilitate Proliferation and Reduce Early Apoptosis of Cardiac Microvascular Endothelial Cell Via PKCβ Signaling Pathway: Insight from Diabetic Cardiomyopathy

NO/cGMP Signal Pathway Involved in the Disturbance of Calcium Homeostasis in Vascular Smooth Muscle During the Late Phase of Sepsis

Alpha-1 Adrenergic Receptor Agonist Phenylephrine Inhibits Sepsis-Induced Cardiomyocyte Apoptosis and Cardiac Dysfunction Via Activating ERK1/2 Signal Pathway.

Endogenous β3-adrenergic receptor activation alleviates sepsis-induced cardiomyocyte apoptosis via PI3K/Akt signaling pathway

Endothelial α1-adrenergic receptor activation improves cardiac function in septic mice via PKC-ERK/p38MAPK signaling pathway

Antiapoptotic effect of endothelin-1 in rat cardiomyocytes in vitro

Inhibition of Endothelin Converting Enzyme-1 Activity or Expression Ameliorates Angiotensin Ii-Induced Myocardial Hypertrophy in Cultured Cardiomyocytes

[Endothelin-1 Overexpression Inhibits Rat Pulmonary Arterial Microvascular Smooth Muscle Cell Apoptosis Via Akt/PKB Pathway].

Change of ET-1 and ETAR in septic shock rats

The Study on Role of Endothelial Cell Autophagy in Rats with Sepsis-Induced Acute Kidney Injury

Calpain-1 Induces Apoptosis in Pulmonary Microvascular Endothelial Cells under Septic Conditions

Abstract 22: Calpain-Dependent Induction of Endoplasmic Reticulum Stress in Cardiomyocyte Apoptosis and Post--Myocardial Infarction Remodeling

Phenylephrine Attenuated Sepsis-Induced Cardiac Inflammation and Mitochondrial Injury Through an Effect on the PI3K/Akt Signaling Pathway

The Angiogenic Factors and Their Soluble Receptors in Sepsis: Friend, Foe, Orboth?

Angiotensin II Induces Apoptosis of Cardiac Microvascular Endothelial Cells Via Regulating PTP1B/PI3K/Akt Pathway.

Cardiac Muscle Cell Hypertrophy and Apoptosis Induced by Distinct Members of the P38 Mitogen-activated Protein Kinase Family*

Abstract 45: Systemic Illness in Ece1 Ablated Adult Mice

Abstract 195: Endothelin Converting Enzyme-1 (ECE1) is Essential in Adult Normal Physiology

Change of ET-1 Mrna and ETAR Mrna Expression in Some Organs in Sepsis and Septic Shock Rats